Efficacy of Intravenous In-line Filter in Patient Undergoing Cardiac Surgery
1 other identifier
interventional
486
1 country
1
Brief Summary
The aim of this study is to demonstrated efficacy of in-line filtration to reduce systemic inflammatory response syndrome (SIRS) ,specific organ dysfunction and complications in adult cardiac surgery. 486 patients undergoing cardiac surgery for acquired heart disease are 1:1 randomized into in-line filtration (study group) and non-filtration (control group). The incidence of SIRS, complications, daily SOFA (sequential organ failure assessment) score are compared between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedStudy Start
First participant enrolled
January 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedMarch 15, 2024
March 1, 2024
4.5 years
November 30, 2018
March 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of SIRS after cardiac surgery
SIRS is diagnosed when patients have two or more of these criteria: 1.Heart rate \>90/min, 2.Temperature \>38 °C or \<36 °C, 3.Respiratory rate \>20/min or Paco2 \<32 mm Hg (4.3 kPa), and 4.White blood cell count \>12000/mm3 or \<4000/mm3 or \>10% immature band.
SIRS is evaluated every 24 hours from immediate post-op to 96 hours postoperatively
Secondary Outcomes (8)
Daily SOFA score
SOFA score is evaluated every 24 hours from immediate post-op to 96 hours postoperatively
Incidence of Operative mortality
up to 1 month postoperatively
Incidence of Permanent Stroke
up to 1 month postoperatively
Incidence of Renal Failure
up to 1 month postoperatively
Incidence of Prolonged Ventilation > 24 hours
up to 1 month postoperatively
- +3 more secondary outcomes
Study Arms (2)
In-line filtration
EXPERIMENTALFor patients randomized to in-line filtration, in-line filters (Pall, Dreieich, Germany) are used for all intravenous access during operation and postoperative period in intensive care unit (ICU).
Control
ACTIVE COMPARATORFor patients randomized to control group, All intravenous access is managed routinely according to local standard care without filtration during operation and postoperative period in ICU.
Interventions
In-line filtration is used during anesthesia and intensive care unit in study group to purify fluids administrations.
Patients are treated with standard intravenous solutions and vascular access management
Eligibility Criteria
You may qualify if:
- Patients age 18 years or older undergoing elective adult cardiac surgery
You may not qualify if:
- Emergency surgery
- Patient who does not want to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ramathibodi Hospital
Bangkok, 10400, Thailand
Related Publications (1)
Sasse M, Dziuba F, Jack T, Koditz H, Kaussen T, Bertram H, Beerbaum P, Boehne M. In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care Patients. Pediatr Cardiol. 2015 Aug;36(6):1270-8. doi: 10.1007/s00246-015-1157-x. Epub 2015 Apr 7.
PMID: 25845941BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Narongrit Kantathut, MD
Ramathibodi hospital, Mahidol University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2018
First Posted
December 24, 2018
Study Start
January 3, 2019
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
March 15, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share